A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.

Item
http://www.wikidata.org/entity/Q33653805
Smoking cessation interventions for smokers with current or past depressionTargeting the noradrenergic system for gender-sensitive medication development for tobacco dependenceEmerging drugs for the treatment of tobacco dependence: 2014 updateTreatment of nicotine addiction: present therapeutic options and pipeline developments.Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessationPharmacotherapies and harm-reduction options for the treatment of tobacco dependence.Differences in smoking expectancies in smokers with and without a history of major depression.Selegiline transdermal system (STS) as an aid for smoking cessation.Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.Therapeutic advances in the treatment of nicotine addiction: present and future.Pharmacotherapy for smoking cessation: current advances and research topics.Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence.Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch.Why are antidepressant drugs effective smoking cessation aids?
P2860

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.

Item
http://www.wikidata.org/entity/Q33653805
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
A double-blind, placebo-contro ...... e-dependent cigarette smokers.
@ast
A double-blind, placebo-contro ...... e-dependent cigarette smokers.
@en
type
label
A double-blind, placebo-contro ...... e-dependent cigarette smokers.
@ast
A double-blind, placebo-contro ...... e-dependent cigarette smokers.
@en
prefLabel
A double-blind, placebo-contro ...... e-dependent cigarette smokers.
@ast
A double-blind, placebo-contro ...... e-dependent cigarette smokers.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
A double-blind, placebo-contro ...... e-dependent cigarette smokers.
@en
P2093
P2860
P304
P31
P356
10.1016/J.DRUGALCDEP.2009.10.009
P433
P478
P50
P577
P5875
P698
P921
P932